Patrick Archdeacon

1.7k total citations
22 papers, 1.2k citations indexed

About

Patrick Archdeacon is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Statistics and Probability. According to data from OpenAlex, Patrick Archdeacon has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 5 papers in Economics and Econometrics and 5 papers in Statistics and Probability. Recurrent topics in Patrick Archdeacon's work include Statistical Methods in Clinical Trials (5 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Patrick Archdeacon is often cited by papers focused on Statistical Methods in Clinical Trials (5 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Patrick Archdeacon collaborates with scholars based in United States and United Kingdom. Patrick Archdeacon's co-authors include Myles H. Akabas, Christine Kaufmann, Arthur Karlin, Renata Albrecht, Jacob L. Meyer, Tiffany Cook, Carolyn Y. Neuland, S Bala, Ana M Guerreiro Hernández and M Cavaillé‐Coll and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Nature Reviews Drug Discovery.

In The Last Decade

Patrick Archdeacon

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Archdeacon United States 15 502 252 202 193 178 22 1.2k
Shashi Amur United States 17 221 0.4× 79 0.3× 35 0.2× 85 0.4× 46 0.3× 25 999
Ron HN van Schaik Netherlands 31 583 1.2× 738 2.9× 24 0.1× 447 2.3× 37 0.2× 92 3.2k
Ann M. Moyer United States 24 541 1.1× 65 0.3× 25 0.1× 143 0.7× 22 0.1× 109 2.1k
Laure Elens Belgium 33 299 0.6× 1.4k 5.5× 30 0.1× 518 2.7× 37 0.2× 88 3.0k
Robert Cramb United Kingdom 22 159 0.3× 131 0.5× 17 0.1× 718 3.7× 96 0.5× 50 1.7k
Samir Mallat Lebanon 18 131 0.3× 138 0.5× 13 0.1× 154 0.8× 195 1.1× 41 911
Gabriele Kirchner Germany 25 356 0.7× 547 2.2× 12 0.1× 681 3.5× 33 0.2× 54 2.0k
Qais Mekki United States 21 561 1.1× 517 2.1× 170 0.8× 691 3.6× 11 0.1× 28 2.3k
Barry D. Kahan United States 26 374 0.7× 1.3k 5.1× 18 0.1× 710 3.7× 128 0.7× 53 2.1k
JJ Swen Netherlands 8 193 0.4× 344 1.4× 14 0.1× 100 0.5× 18 0.1× 10 1.4k

Countries citing papers authored by Patrick Archdeacon

Since Specialization
Citations

This map shows the geographic impact of Patrick Archdeacon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Archdeacon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Archdeacon more than expected).

Fields of papers citing papers by Patrick Archdeacon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Archdeacon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Archdeacon. The network helps show where Patrick Archdeacon may publish in the future.

Co-authorship network of co-authors of Patrick Archdeacon

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Archdeacon. A scholar is included among the top collaborators of Patrick Archdeacon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Archdeacon. Patrick Archdeacon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cocoros, Noelle M., Sean D. Pokorney, Kevin Haynes, et al.. (2018). FDA-Catalyst—Using FDA’s Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trial. Clinical Trials. 16(1). 90–97. 14 indexed citations
2.
Carnahan, Ryan M., Jennifer L. Kuntz, Shirley Wang, et al.. (2018). Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug‐outcome associations: The case of clindamycin and Clostridium difficile infection. Pharmacoepidemiology and Drug Safety. 27(7). 731–739. 6 indexed citations
3.
Wang, Shirley, Charles E. Leonard, Joshua J. Gagne, et al.. (2017). Sentinel Modular Program for Propensity Score–Matched Cohort Analyses. Epidemiology. 28(6). 838–846. 29 indexed citations
4.
Perez, Raymond P., Patrick Archdeacon, Nancy Roach, et al.. (2017). Sponsors’ and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials. Clinical Trials. 14(3). 225–233. 6 indexed citations
5.
Linde, Peter G., Patrick Archdeacon, Matthew D. Breyer, et al.. (2016). Overcoming Barriers in Kidney Health—Forging a Platform for Innovation. Journal of the American Society of Nephrology. 27(7). 1902–1910. 23 indexed citations
6.
Calis, Karim A., Patrick Archdeacon, Raymond P. Bain, et al.. (2016). Understanding the functions and operations of data monitoring committees: Survey and focus group findings. Clinical Trials. 14(1). 59–66. 14 indexed citations
7.
Han, Xiaopeng, Sean Hennessy, Elizabeth A. Chrischilles, et al.. (2016). Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug‐Adverse Event Association. Clinical Pharmacology & Therapeutics. 100(5). 558–564. 27 indexed citations
8.
Drawz, Paul E., Patrick Archdeacon, Clement J. McDonald, et al.. (2015). CKD as a Model for Improving Chronic Disease Care through Electronic Health Records. Clinical Journal of the American Society of Nephrology. 10(8). 1488–1499. 47 indexed citations
9.
Nolin, Thomas D., George R. Aronoff, William H. Fissell, et al.. (2014). Pharmacokinetic Assessment in Patients Receiving Continuous RRT. Clinical Journal of the American Society of Nephrology. 10(1). 159–164. 35 indexed citations
10.
Tenaerts, Pamela, et al.. (2014). The Clinical Trials Transformation Initiative: innovation through collaboration. Nature Reviews Drug Discovery. 13(11). 797–798. 23 indexed citations
11.
Raebel, Marsha A., Kevin Haynes, Tiffany S. Woodworth, et al.. (2014). Electronic clinical laboratory test results data tables: lessons from Mini‐Sentinel. Pharmacoepidemiology and Drug Safety. 23(6). 609–618. 29 indexed citations
12.
Archdeacon, Patrick, et al.. (2013). Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application. Therapeutic Innovation & Regulatory Science. 48(2). 200–207. 13 indexed citations
13.
Archdeacon, Patrick, Rachel Shaffer, Wolfgang C. Winkelmayer­, Ronald J. Falk, & Prabir Roy‐Chaudhury. (2013). Fostering Innovation, Advancing Patient Safety. Clinical Journal of the American Society of Nephrology. 8(9). 1609–1617. 40 indexed citations
14.
Cavaillé‐Coll, M, S Bala, Ergun Velidedeoğlu, et al.. (2013). Summary of FDA Workshop on Ischemia Reperfusion Injury in Kidney Transplantation. American Journal of Transplantation. 13(5). 1134–1148. 111 indexed citations
15.
Archdeacon, Patrick, et al.. (2013). FDA Perspective. Transplantation. 95(7). 916–918. 7 indexed citations
16.
Archdeacon, Patrick, et al.. (2012). Summary of the US FDA Approval of Belatacept. American Journal of Transplantation. 12(3). 554–562. 86 indexed citations
17.
Archdeacon, Patrick, Marieta Chan, Carolyn Y. Neuland, et al.. (2011). Summary of FDA Antibody-Mediated Rejection Workshop. American Journal of Transplantation. 11(5). 896–906. 139 indexed citations
18.
Archdeacon, Patrick & Randal K. Detwiler. (2008). Bone Morphogenetic Protein 7 (BMP7): A Critical Role in Kidney Development and a Putative Modulator of Kidney Injury. Advances in Chronic Kidney Disease. 15(3). 314–320. 13 indexed citations
19.
Akabas, Myles H., Christine Kaufmann, Patrick Archdeacon, & Arthur Karlin. (1994). Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the α subunit. Neuron. 13(4). 919–927. 371 indexed citations
20.
Akabas, Myles H., Christine Kaufmann, Tiffany Cook, & Patrick Archdeacon. (1994). Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator.. Journal of Biological Chemistry. 269(21). 14865–14868. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shashi Amur Breakdown of academic impact, for papers by Ron HN van Schaik Breakdown of academic impact, for papers by Ann M. Moyer Breakdown of academic impact, for papers by Laure Elens Breakdown of academic impact, for papers by Robert Cramb Breakdown of academic impact, for papers by Samir Mallat Breakdown of academic impact, for papers by Gabriele Kirchner Breakdown of academic impact, for papers by Qais Mekki Breakdown of academic impact, for papers by Barry D. Kahan Breakdown of academic impact, for papers by JJ Swen
Rankless by CCL
2026